Peer review reports
From: Osteopontin isoform c promotes the survival of cisplatin-treated NSCLC cells involving NFATc2-mediated suppression on calcium-induced ROS levels
Original Submission |
1 Mar 2021 |
Submitted |
Original manuscript
|
Resubmission - Version 2 |
|
Submitted |
Manuscript version 2
|
Resubmission - Version 3 |
|
Submitted |
Manuscript version 3
|
7 Apr 2021 |
Reviewed |
Reviewer Report
|
17 May 2021 |
Author responded |
Author comments - Shan Cheng
|
Resubmission - Version 4 |
17 May 2021 |
Submitted |
Manuscript version 4
|
25 May 2021 |
Author responded |
Author comments - Shan Cheng
|
Resubmission - Version 5 |
25 May 2021 |
Submitted |
Manuscript version 5
|
Publishing |
9 Jun 2021 |
Editorially accepted |
|
29 Jun 2021 |
Article published |
10.1186/s12885-021-08495-z
|
Learn about peer review